Use of incretin agents and risk of acute and chronic pancreatitis: A population‐based cohort study

@article{Knapen2017UseOI,
  title={Use of incretin agents and risk of acute and chronic pancreatitis: A population‐based cohort study},
  author={Lotte M Knapen and R J Baatenburg de Jong and Johanna H. M. Driessen and Y. C. A. Keulemans and Nielka P van Erp and Marie L De Bruin and Hubert G. M. Leufkens and Sander Croes and Frank de Vries},
  journal={Diabetes, Obesity and Metabolism},
  year={2017},
  volume={19},
  pages={401–411}
}
  • Lotte M Knapen, R J Baatenburg de Jong, +6 authors Frank de Vries
  • Published in
    Diabetes, obesity…
    2017
  • Medicine
  • AIM To determine the association between the use of incretin agents (dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists) for the treatment of type 2 diabetes mellitus (T2DM) and the risk of any, acute and chronic pancreatitis. RESEARCH DESIGN AND METHODS A population-based cohort study was conducted using data from the UK Clinical Practice Research Datalink (CPRD 2007-2012). A total of 182 428 adult patients with ≥1 non-insulin antidiabetic drug (NIAD… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    5
    Twitter Mentions

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 12 CITATIONS

    The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect

    VIEW 1 EXCERPT
    CITES RESULTS

    iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 47 REFERENCES

    Data Resource Profile: Clinical Practice Research Datalink (CPRD)

    VIEW 1 EXCERPT

    Evaluating pancreatitis in primary care: a population-based cohort study